NM_152416.4(NDUFAF6):c.513C>G (p.Ile171Met) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 13, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002959015.2

Allele description [Variation Report for NM_152416.4(NDUFAF6):c.513C>G (p.Ile171Met)]

NM_152416.4(NDUFAF6):c.513C>G (p.Ile171Met)

Gene:

NDUFAF6:NADH:ubiquinone oxidoreductase complex assembly factor 6 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

8q22.1

Genomic location:

Preferred name:

NM_152416.4(NDUFAF6):c.513C>G (p.Ile171Met)

HGVS:

NC_000008.11:g.95045580C>G
NG_016647.2:g.155310C>G
NM_001330582.2:c.237C>G
NM_001354514.2:c.237C>G
NM_001354515.2:c.237C>G
NM_001354516.2:c.357C>G
NM_001354517.2:c.180C>G
NM_001354518.2:c.180C>G
NM_001354519.2:c.180C>G
NM_001354521.2:c.237C>G
NM_001354522.2:c.57C>G
NM_001354524.2:c.57C>G
NM_001354525.2:c.57C>G
NM_001354527.2:c.57C>G
NM_001354528.2:c.57C>G
NM_001354529.2:c.57C>G
NM_001354530.2:c.57C>G
NM_001354531.2:c.57C>G
NM_001354532.2:c.57C>G
NM_001354533.2:c.57C>G
NM_001354534.2:c.180C>G
NM_152416.2:c.513C>G
NM_152416.4:c.513C>GMANE SELECT
NP_001317511.1:p.Ile79Met
NP_001341443.1:p.Ile79Met
NP_001341444.1:p.Ile79Met
NP_001341445.1:p.Ile119Met
NP_001341446.1:p.Ile60Met
NP_001341447.1:p.Ile60Met
NP_001341448.1:p.Ile60Met
NP_001341450.1:p.Ile79Met
NP_001341451.1:p.Ile19Met
NP_001341453.1:p.Ile19Met
NP_001341454.1:p.Ile19Met
NP_001341456.1:p.Ile19Met
NP_001341457.1:p.Ile19Met
NP_001341458.1:p.Ile19Met
NP_001341459.1:p.Ile19Met
NP_001341460.1:p.Ile19Met
NP_001341461.1:p.Ile19Met
NP_001341462.1:p.Ile19Met
NP_001341463.1:p.Ile60Met
NP_689629.2:p.Ile171Met
NC_000008.10:g.96057808C>G
NR_148910.2:n.652C>G
NR_148911.2:n.652C>G
NR_148912.2:n.656C>G
NR_148913.2:n.533C>G
NR_148914.2:n.730C>G
NR_148915.2:n.657C>G

Protein change:

I119M

Molecular consequence:

NM_001330582.2:c.237C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354514.2:c.237C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354515.2:c.237C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354516.2:c.357C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354517.2:c.180C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354518.2:c.180C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354519.2:c.180C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354521.2:c.237C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354522.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354524.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354525.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354527.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354528.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354529.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354530.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354531.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354532.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354533.2:c.57C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001354534.2:c.180C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_152416.4:c.513C>G - missense variant - [Sequence Ontology: SO:0001583]
NR_148910.2:n.652C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148911.2:n.652C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148912.2:n.656C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148913.2:n.533C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148914.2:n.730C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148915.2:n.657C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Borrelia afzelii Tom3107 plasmid cp26, complete sequence
Borrelia afzelii Tom3107 plasmid cp26, complete sequence
gi|672921543|gnl|PRJNA218503|PRJNA2 cp26_plasmid|gb|CP009213.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003282066	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Oct 13, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003282066

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Oct 13, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003282066.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 171 of the NDUFAF6 protein (p.Ile171Met). This variant is present in population databases (rs200347396, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with NDUFAF6-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NDUFAF6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine